Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603811'
s OCF Margin % Range Over the Past 10 Years
Min: 19.73 Med: 25.95 Max: 34.52
Current: 33.72
During the past 13 years, the highest OCF Margin % of Zhejiang Cheng Yi Pharmaceutical Co was 34.52%. The lowest was 19.73%. And the median was 25.95%.
SHSE:603811's OCF Margin % is ranked better than 94.91% of 963
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs SHSE:603811: 33.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Cheng Yi Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Cheng Yi Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) has a OCF Margin % of 26.98% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors. This is near median its historical median of 25.95. Over the past decade, Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin % has ranged from 19.73 to 34.52. According to the industry distribution chart, Zhejiang Cheng Yi Pharmaceutical Co ranks #49 out of 963 companies in the Drug Manufacturers industry, placing it in the top 5.1%.
Is Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin % too high?
Zhejiang Cheng Yi Pharmaceutical Co's current OCF Margin % of 26.98% is near median its 10-year median of 25.95. Over the past 10 years, this metric has ranged from a low of 19.73 to a high of 34.52. The Drug Manufacturers industry median OCF Margin % is 9.94. Zhejiang Cheng Yi Pharmaceutical Co's value of 26.98% is 171.4% above this industry median. Based on the distribution chart, Zhejiang Cheng Yi Pharmaceutical Co ranks #49 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Cheng Yi Pharmaceutical Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Cheng Yi Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Cheng Yi Pharmaceutical Co ranks #49 out of 963 companies for OCF Margin %. This places Zhejiang Cheng Yi Pharmaceutical Co in the top 5% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Zhejiang Cheng Yi Pharmaceutical Co's value of 26.98% is 171.4% above this benchmark. Historically, Zhejiang Cheng Yi Pharmaceutical Co's own OCF Margin % has ranged from 19.73 to 34.52 over the past decade. While the company's 10-year median is 25.95 vs. the industry median of 9.94, Zhejiang Cheng Yi Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Cheng Yi Pharmaceutical Co's current OCF Margin % of 26.98% is 171.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zhejiang Cheng Yi Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Cheng Yi Pharmaceutical Co's current OCF Margin % is 26.98%, which is near median its own 10-year median of 25.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Cheng Yi Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥8.46, compared to a current price of ¥7.43 — trading 12.2% below its estimated fair value. The current OCF Margin % is 26.98%, which is near median its 10-year median of 25.95 and 171.4% above the Drug Manufacturers industry median of 9.94. Zhejiang Cheng Yi Pharmaceutical Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811), the current OCF Margin % is 26.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Cheng Yi Pharmaceutical Co (SHSE:603811) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Cheng Yi Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥7.43 is trading 12.2% below its estimated GF Value™ of ¥8.46.
GuruFocus considers Zhejiang Cheng Yi Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for SHSE:603811:
OCF Margin %: 26.98% (near median its 10-year median of 25.95)
GF Value™: ¥8.46 vs. price of ¥7.43 (12.2% below fair value)
Industry Position: 171.4% above the Drug Manufacturers median (#49 of 963)
No single metric tells the full story. See the SHSE:603811 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Cheng Yi Pharmaceutical Co Ltd is a pharmaceutical company that produces capsules, injections, tablets, APIs, and pharmaceutical intermediates in China. Its main products include glucosamine hydrochloride raw materials and preparations, torasemide injection and capsules, Gastrodin raw materials, ribavirin and purine raw materials, and so on.
85GF Score
Get the complete analysis for SHSE:603811
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603811 has been successfully added to your 
